Skip to Content
Biotechnology

A man caught coronavirus twice—and it was worse the second time

That makes him the fifth recorded person to have caught the coronavirus twice—and raises more questions about how immunity might work.
October 13, 2020
A drive-up testing station in the parking lot of UNLV Medicine in Las Vegas, Nevada.
A drive-up testing station in the parking lot of UNLV Medicine in Las Vegas, Nevada.
A drive-up testing station in the parking lot of UNLV Medicine in Las Vegas, Nevada.Getty

The news: A man in the US caught covid-19 for a second time in the space of just two months, according to a study published in The Lancet Infectious Diseases. That makes him the fifth person to have officially caught the coronavirus twice, after cases recorded in Hong Kong, Belgium, Ecuador, and the Netherlands (and there will certainly be more cases we don't know about). However, what’s strange about his case is that he had had a worse bout of illness the second time. His doctors compared the genome of the virus during the two illnesses and found they were too different to have been caused by the same infection. There’s only one other recorded instance where this has happened—the case in Ecuador.

The details: The 25-year-old man tested positive for the first time on April 18, after experiencing several weeks of symptoms including sore throat, cough, headache, nausea, and diarrhea. He felt fully recovered by April 27, and tested negative for the virus on both May 9 and 26. But just two days later, on May 28, he developed symptoms again, this time with fever and dizziness too. He tested positive on June 5 and needed to be hospitalized after his lungs were unable to get enough oxygen into his body, causing hypoxia and shortness of breath. He had no underlying health conditions. The man has now recovered.

The significance: Being infected once does not mean you’re protected from being infected again, even if such cases are still vanishingly rare, with just five identified out of nearly 40 million confirmed cases worldwide. That means people who have had covid-19 still need to stay vigilant, following the advice on social distancing, wearing face masks, and avoiding crowded, poorly ventilated spaces. This was not altogether unexpected: coronavirus experts warned us that other coronaviruses, such as the common cold, are seasonal. However, there are still many questions that researchers are racing to answer. How much protection does having covid-19 confer? Is that mainly through antibodies or T cells? How long does protection last? What does it mean for the medical treatments that are being developed, or for vaccines? Will we all require a yearly shot rather than a one-off vaccine, for example? If nothing else, this new case is a reminder of how much about this virus we still don’t know.

Deep Dive

Biotechnology

Muhammad bin Salman funds anti-aging research
Muhammad bin Salman funds anti-aging research

Saudi Arabia plans to spend $1 billion a year discovering treatments to slow aging

The oil kingdom fears that its population is aging at an accelerated rate and hopes to test drugs to reverse the problem. First up might be the diabetes drug metformin.

individual aging affects covid outcomes concept
individual aging affects covid outcomes concept

Anti-aging drugs are being tested as a way to treat covid

Drugs that rejuvenate our immune systems and make us biologically younger could help protect us from the disease’s worst effects.

Workers disinfect the street outside Shijiazhuang Railway Station
Workers disinfect the street outside Shijiazhuang Railway Station

Why China is still obsessed with disinfecting everything

Most public health bodies dealing with covid have long since moved on from the idea of surface transmission. China’s didn’t—and that helps it control the narrative about the disease’s origins and danger.

person carrying styrofoam box used for transporting human organs
person carrying styrofoam box used for transporting human organs

A new storage technique could vastly expand the number of livers available for transplant

It allows donor livers to be held for days—significantly longer than the standard now–and even treated if they are damaged.

Stay connected

Illustration by Rose WongIllustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at customer-service@technologyreview.com with a list of newsletters you’d like to receive.